로딩 중…
지수 로딩 중…
Compass Therapeutics, Inc.
CMPX· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$1.89-1.31%
2026-08-03
Financials
Valuation Metrics
Compass Therapeutics, Inc.'s Market Cap is $339M. At end of 2025 it was $993M. Ranked #2932 of 3,112 in US market (top 94%), #1308 of 1,445 on NASDAQ (top 91%), #239 of 269 in Pharmaceuticals, Biotechnology & Life Sciences (top 89%) by Market Cap.
Investment Metrics(as of 2026-08-03)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $339M | US#2,932/3,112 Sec#239/269 |
| Revenue | $0.00 | US#2,974/3,112 Sec#204/269 |
| Net Income | $-68M | US—/3,112 Sec—/269 |
| Total Assets | $205M | US#2,975/3,112 Sec#249/269 |
| Net Assets | $186M | US#2,756/3,112 Sec#203/269 |
| Value | ||
| P/B | 1.82x | US#1,083/3,112 Sec#48/269 |
| FCF Yield | -15.70% | US—/3,112 Sec—/269 |
| Profitability | ||
| ROE | -36.56% | US#2,671/3,112 Sec#143/269 |
| ROA | -33.23% | US#2,888/3,112 Sec#168/269 |
| Revenue Growth | -100.00% | US#2,948/3,112 Sec#190/269 |
| Financial Health | ||
| Debt Ratio | 10.03% | US#111/3,112 Sec#48/269 |
| Total Debt | $10M | US#2,787/3,112 Sec#198/269 |
| FCF | $-53M | US#2,473/3,112 Sec#115/269 |
| Cash | $55M | US#2,538/3,112 Sec#219/269 |
| Current Ratio | 19.04x | US#129/3,112 Sec#34/269 |
| Performance | ||
| 1Y Return | -36.10% | US#2,804/3,112 Sec#232/269 |
| 1M Return | -16.96% | US#2,880/3,112 Sec#220/269 |
| From 52W High | -72.60% | US#3,041/3,112 Sec#256/269 |
| 1Y MDD | -75.04% | US#2,998/3,112 Sec#252/269 |
| Trading | ||
| Volume | 3,483,041 shares | US#542/3,112 Sec#41/269 |
| Trading Value | $7M | US#2,545/3,112 Sec#207/269 |
| Per Share | ||
| EPS | $-0.36 | US—/3,112 Sec—/269 |
| BPS | $1.06 | US#2,617/3,112 Sec#201/269 |